The decarboxylation of 6-[F-18]fluorodopa (FDOPA) and retention of the prod
uct [F-18]fluorodopamine within vesicles of catecholamine fibers results in
the labeling of dopamine-rich brain regions during FDOPA/PET studies. Howe
ver, this metabolic trapping is not irreversible due to the eventual diffus
ion of [F-18]fluorodopamine metabolites from brain. Consequently, time-radi
oactivity recordings of striatum are progressively influenced by metabolite
loss. In linear analyses, the net blood-brain clearance of FDOPA (K-i(D),
ml g(-1) min(-1)) can be corrected for this loss by the elimination rate co
nstant k(cl)(Lin) (min(-1)). Similarly,. the DOPA decarboxylation rate cons
tant (k(3)(D), min(-1)) calculated by compartmental analysis can also be co
rrected for metabolite loss by the elimination rate constant k(9)(DA) (min(
-1)). To compare the two methods, we calculated the two elimination rate, c
onstants using data recorded during 240 min of FDOPA circulation in normal
monkeys and in monkeys with unilateral 1-methyl-4-phenyl-1,2,3,6-tetrahydro
pyridine (MPTP) lesions. Use of the extended models increased the magnitude
s of K-i(D) and k(3)(D) in striatum; in the case of k(3)(D), variance of th
e estimate was substantially improved upon correction for metabolite loss.
The rate constants for metabolite loss were higher in MPTP-lesioned monkey
striatum than in normal striatum. The high correlation between individual e
stimates of k(cl)(Lin) and k(9)(DA) suggests that both rate constants revea
l loss of decarboxylated metabolites from brain. Synapse 41:212-218, 2001.
(C) 2001 Wiley-Liss, Inc.